CHICAGO, Nov. 21, 2019 /PRNewswire/ -- According to the new market research report "Point Of Care Diagnostics Market by Product (Glucose, Infectious Disease (Hepatitis C, Influenza, Respiratory), Coagulation), Platform (Microfluidics, Immunoassays), Mode (Prescription & OTC), End-User (Hospitals, Home Care) - Global Forecast to 2024", published by MarketsandMarkets™, the global Point Of Care Diagnostics Market is projected to reach USD 46.7 billion by 2024 from USD 28.5 billion in 2019, at a CAGR of 10.4% during the forecast period.
Download PDF Brochure:
Factors such as the high prevalence of infectious diseases in developing countries, increasing incidence of target conditions, rising preference for home healthcare across the globe, and growing government initiatives supporting the adoption of POC diagnostic products are driving the growth of the during the study period.
Based on product, the glucose monitoring products segment is expected to account for the largest share of the POC Diagnostics Market in 2019
Based on product, the Point Of Care Diagnostics Market is segmented into glucose monitoring products, infectious disease testing products, coagulation monitoring products, cardiometabolic monitoring products, hematology testing products, urinalysis testing products, cholesterol testing products, drugs-of-abuse testing products, tumor/cancer marker testing products, pregnancy & fertility testing products, fecal occult testing products, and other POC products. The glucose monitoring products segment is expected to account for the largest share of the POC Diagnostics Market in 2019. The large share of this segment can be attributed to the growing prevalence of diabetes and the rising inclination of patients towards home testing.
Browse in-depth TOC on "Point Of Care Diagnostics Market"
99 – Tables
31 – Figures
189 – Pages
Based on platform, the lateral flow assays segment dominates the POC Diagnostics Market in 2019
Based on platform, the Point Of Care Diagnostics Market is segmented into lateral flow assays, immunoassays, molecular diagnostics, dipsticks, and microfluidics. The lateral flow assays segment is expected to account for the largest market share in 2019. The large share of this segment is attributed to the increasing adoption of lateral flow assays in POC testing as a replacement for lengthy, conventional laboratory procedures.
Based on end user, the home care settings segment is expected to register the highest growth rate during the forecast period
Based on end user, the Point Of Care Diagnostics Market is segmented into clinical laboratories and outpatient healthcare & ambulatory care settings, hospitals/critical care centers, home care settings, and other end users. The home care settings segment is expected to grow at the highest CAGR during the forecast period. The high growth of this segment can be attributed to the increasing preference for home and remote monitoring and rising demand for rapid tests among home care users.
Get 10% Customization on this Research Report:
North America will continue to dominate the Point Of Care Diagnostics Market in 2024
The Point Of Care Diagnostics Market, by region, is segmented into North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. North America is estimated to account for the largest share of the market in 2019. This can be attributed to the growing prevalence of lifestyle diseases, increasing number of product approvals, and rising government initiatives to support the adoption of POC in this region.
Prominent players in this market are Abbott (US), Roche (Switzerland), Siemens (Germany), Danaher (US), Becton, Dickinson, and Company (US), Johnson & Johnson (US), Instrumentation Laboratory (US), PTS Diagnostics (US), Quidel (US), Chembio Diagnostic Systems (US), Sekisui Diagnostics (US), Nova Biomedical (US), EKF Diagnostics (UK), AccuBioTech (China), and Trinity Biotech (Ireland).
Browse Adjacent Markets: Medical Devices Market Research Reports & Consulting
Browse Related Reports:
Point of Care Molecular Diagnostics Market by Product & Service (Assays, Kits, Analyzers, Software), Application (Respiratory Disease, Hospital Acquired Infection), Technology (RT-PCR, INAAT), End User (Physician Office, ICUS) - Global Forecast to 2023
In Vitro Diagnostics Market by Product (Instruments, Reagents), Technology (Immunoassay, Clinical Chemistry, Molecular Diagnostics, Hematology, Urinalysis), Application (Diabetes, Oncology, Cardiology, Nephrology) - Forecast to 2023
MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies' revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.
Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.
MarketsandMarkets's flagship competitive intelligence and market research platform, "Knowledge Store" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.
Mr. Shelly Singh
630 Dundee Road
Northbrook, IL 60062
Email: [email protected]
Research Insight: https://www.marketsandmarkets.com/ResearchInsight/point-of-care-diagnostic-market.asp
Visit Our Website: https://www.marketsandmarkets.com
Content Source: https://www.marketsandmarkets.com/PressReleases/point-of-care-diagnostic.asp